Thanks for reposting your astute insights about “big pharma” 😶
Fact ✅️: Two of NWBO’s pipeline products are currently in clinical trials with Merck’s pembrolizumab, & Roswell partnered with NWBO for a licensing deal…
In addition to DCVax®-L at UCLA, Roswell’s aDC1platform has also reached Phase II in COMBO with commercial drugs (checkpoint inhibitors & TLR agonists).
For example, This Roswell PII clinical trial is active & posted an update on Dec 30th. Moffitt is included on its list of trial sites, & it’s funded by a peer-reviewed grant awarded by the 🇺🇸U.S. DoD: